Apyx Medical Corporation APYX 深 沪
等待开盘 04-02 09:30:00 美东时间
3.63
-0.060
-1.63%
华盛通- 最 高3.865
- 今 开3.68
- 成交量 6.93万股
- 最 低 3.62
- 昨 收 3.69
- 总市值 1.52亿
- 52周最高 4.50
- 市盈率 静 --
- 换手率 0.17%
- 52周最低 0.8252
- 委 比 -61.29%
- 总股本 4182.92万
- 历史最高 17.50
- 量 比 1.30
- 振 幅 6.64%
- 历史最低 0.7554
- 每 手 1
- 风险率 1.03%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Renuvion wins 2026 NewBeauty Award for "Best Minimally Invasive Skin Tightener"
Renuvion continues to lead in minimally invasive body contouring as the trusted solution for loose skin. CLEARWATER, Fla., April 1, 2026 /PRNewswire/ -- Apyx Medical Corporation (NASDAQ: APY...
04-01 21:30
美股大行评级 | 甲骨文绩后分歧大！小摩上调评级至"超配"，目标价缺降至210美元；科尔士百货、AVAV、Blend Labs、Domo遭多家大行下调评级
今日重点评级关注：LUCID CAPITAL MARKETS：上调INmune Bio评级至"买入" 目标价从2美元升至9美元；Clear Street：维持MoonLake Immunotherapeutics Class A"买入"评级，目标价从45美元升至70美元
03-12 12:34
Earnings Scheduled For March 10, 2026
Companies Reporting Before The Bell • Ultralife (NASDAQ:ULBI) is likely to repo...
03-10 19:11
Apyx Medical Q4 revenue beats on Surgical Aesthetics unit strength
Apyx Medical Q4 revenue beats on Surgical Aesthetics unit strength Overview Surgical aesthetics firm's Q4 revenue rose 34.7% yr/yr, beating analyst expectations Adjusted EBITDA for Q4 was positive, beating analyst estimates Company scaling U.S. launch of AYON Body Contouring System amid strong deman
03-10 19:08
Apyx Medical Q4 2025 revenue rises 35% to USD 19.16 million as net loss narrows to USD 1.3 million
Apyx Medical Q4 2025 revenue rises 35% to USD 19.16 million as net loss narrows to USD 1.3 million Apyx Medical reported Q4 FY2025 total revenue of USD 19.16 million, up 35%, driven by a nearly 50% increase in U.S. sales in its Surgical Aesthetics segment. Q4 Surgical Aesthetics revenue was USD 16.7
03-10 19:06
Earnings Breakdown: Apyx Medical Q4
The Q4 earnings report for Apyx Medical (NASDAQ:APYX) was released on Tuesday, ...
03-10 19:02
Apyx Medical Sees FY2026 Sales $57.500M-$58.500M vs $55.480M Est
Apyx Medical (NASDAQ:APYX) sees FY2026 sales of $57.500 million-$58.500 million vs $55.480 million analyst estimate.
03-10 19:01
Apyx Medical Q4 EPS $(0.03) Beats $(0.06) Estimate, Sales $19.164M Beat $18.160M Estimate
Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.06) by 46.43 percent. This is a 75 percent increase over losses of $(0.12) per share from the
03-10 19:01
BRIEF-Apyx Medical Corporation Q4 EPS USD -0.03
BRIEF-Apyx Medical Corporation Q4 EPS USD -0.03 Mar 10 (Reuters) - Apyx Medical Corporation Q4 net income USD -1.24 million. Q4 pretax profit USD -1.146 million Q4 sales USD 19.164 million vs. IBES estimate USD 18.4 million Q4 income from operations USD 11 thousand Q4 adjusted EBITDA USD 689 thousan
03-10 19:00
A Preview Of Apyx Medical's Earnings
Apyx Medical (NASDAQ:APYX) will release its quarterly earnings report on Tuesda...
03-10 01:02
